Olmesartan HCTZ 20-12.5 Recall: Latest FDA Actions, Companies, and Market Impact
Finance
The latest public data show ongoing voluntary recalls of certain olmesartan medoxomil and hydrochlorothiazide tablets, including the 20-12.5 mg strength, due to nitrosamine impu...
Open article